Tag: EZH2

Eisai

Eisai’s Tazemetostat Approved as Orphan Drug in Japan

Eisai Co., Ltd. announced that it has received orphan drug designation for anticancer agent the EZH2 inhibitor tazemetostat…

By

NewsDesk

Join Our Community

First Name

Last Name

Email Address

Country

I have read and agree to the Terms & Conditions

Join Our Community

First Name

Last Name

Email Address

Country

I have read and agree to the Terms & Conditions